Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O43497: Variant p.Ala961Thr

Voltage-dependent T-type calcium channel subunit alpha-1G
Gene: CACNA1G
Feedback?
Variant information Variant position: help 961 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Alanine (A) to Threonine (T) at position 961 (A961T, p.Ala961Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and hydrophobic (A) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In SCA42ND; gain-of-function mutation; results in slower channel inactivation and negatively shifted potential for half-inactivation. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 961 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 2377 The length of the canonical sequence.
Location on the sequence: help ALYFIALMTFGNYVLFNLLV A ILVEGFQAEEISKREDASGQ The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         ALYFIALMTFGNYVLFNLLVAILVEGFQAEEISKREDASGQ

Rat                           ALYFIALMTFGNYVLFNLLVAILVEGFQAE-----------
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 2377 Voltage-dependent T-type calcium channel subunit alpha-1G
Transmembrane 940 – 964 Helical; Name=S6 of repeat II
Repeat 729 – 967 II
Helix 955 – 967



Literature citations
De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene.
Chemin J.; Siquier-Pernet K.; Nicouleau M.; Barcia G.; Ahmad A.; Medina-Cano D.; Hanein S.; Altin N.; Hubert L.; Bole-Feysot C.; Fourage C.; Nitschke P.; Thevenon J.; Rio M.; Blanc P.; Vidal C.; Bahi-Buisson N.; Desguerre I.; Munnich A.; Lyonnet S.; Boddaert N.; Fassi E.; Shinawi M.; Zimmerman H.; Amiel J.; Faivre L.; Colleaux L.; Lory P.; Cantagrel V.;
Brain 141:1998-2013(2018)
Cited for: INVOLVEMENT IN SCA42ND; FUNCTION; VARIANTS SCA42ND THR-961 AND VAL-1531; CHARACTERIZATION OF VARIANTS SCA42ND THR-961 AND VAL-1531;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.